RIO DE JANEIRO, July 8 /PRNewswire-FirstCall/ -- Amil Participacoes S.A. ("Amilpar") (BOVESPA: AMIL3) , in accordance with CVM Instruction 358, of January 3, 2002, informs that CVM - Comissao de Valores Mobiliarios (Brazilian Securities and Exchange Commission), approved on July 7, 2010 the request for the cancellation of the public company register of Medial Saude S.A. ("Medial").
Due to Medial's register cancellation, Amilpar now is the only listed and publicly traded company in the group.
To access the .pdf version of the Press Release visit our website at http://www.amilpar.com.br/ir
IR Contact Erwin Kleuser Investor Relations Officer Phone: +55 (21) 3805-1155 invest@amil.com.br http://www.amilpar.com.br/ir About Amilpar
Amil Participacoes S.A. is the largest health care company in Brazil, according to the ANS, currently assisting over 5 million members in the states of Sao Paulo, Rio de Janeiro, Parana, Minas Gerais, Pernambuco, Bahia and in Distrito Federal. It is also the managed care organization with the largest provider network in the country, including over (i) 3,600 hospitals; (ii) 62,000 polyclinics and outpatient facilities; and (iii) 11,200 laboratories and diagnostic imaging centers. Amil began its activities in 1978 and offers a wide range of healthcare plans for small, medium and large companies, as well as plans for individuals from all income segments, offering its members access to carefully selected healthcare service providers.
Amil Participacoes S.A
CONTACT: IR Contact, Erwin Kleuser, Investor Relations Officer,
+011-55-21-3805-1155, invest@amil.com.br
Web Site: http://www.amilpar.com.br/ir
